Crossingbridge Advisors’s Iris Acquisition Corp II IRAB Stock Holding History

Crossingbridge Advisors’s Portfolio IRAB Stock Details IRAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.48M	Buy	+350,000	New	+$3.47M	0.61%	58

Other funds holding IRAB

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.76B AUM 23.76% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Crossingbridge Advisors's IRAB Position: Q2 2026 in Review

Crossingbridge Advisors opened a new position in Iris Acquisition Corp II (IRAB) in Q2 2026: 350,000 shares worth $3.48M. The stake represents 0.61% of the portfolio and ranks #58 among its holdings.

43 funds tracked by Wall St. Rank hold IRAB as of Q2 2026.

Crossingbridge Advisors held 350,000 shares of Iris Acquisition Corp II worth $3.48M as of Q2 2026.
Iris Acquisition Corp II was a new Crossingbridge Advisors position in Q2 2026.
Iris Acquisition Corp II made up 0.61% of Crossingbridge Advisors's portfolio in Q2 2026, its #58 holding.
43 funds tracked by Wall St. Rank held Iris Acquisition Corp II as of Q2 2026.

Based on Crossingbridge Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.